<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39455598</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2055-1010</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>NPJ primary care respiratory medicine</Title><ISOAbbreviation>NPJ Prim Care Respir Med</ISOAbbreviation></Journal><ArticleTitle>Living with COPD and its psychological effects on participating in community-based physical activity in Brazil: a qualitative study. Findings from the Breathe Well group.</ArticleTitle><Pagination><StartPage>33</StartPage><MedlinePgn>33</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">33</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41533-024-00386-7</ELocationID><Abstract><AbstractText>Physical activity (PA) improves dyspnoea, psychological wellbeing and quality of life (QoL) for people with COPD reducing their risk of exacerbation. However, engagement in PA is low especially amongst those with anxiety and depression, and PA programmes are limited in countries with limited resources such as Brazil. We explored perceptions of 21 people with COPD about the impact of their disease on taking part in community-based PA programmes in Sao Paulo, Brazil through semi-structured telephone interviews from October 2020 to April 2021. Discussions were audio-recorded, transcribed, and analysed using the Framework method. Five themes were identified: Knowledge about COPD and its management; Self-perception of life with COPD; Knowledge and experiences of depression and anxiety; Opinions on PA and repercussions of COVID-19. PA was considered to be important in bringing physical and mental health benefits but there were barriers in accessibility of formal PR programmes and therefore local community PA programmes were considered to be important. People with mental health conditions tended to view PA more negatively. COVID-19 had reduced PA opportunities, access to COPD treatment and social interaction, and was associated with more exacerbations and emotional suffering. In general, this study showed an urgent need to improve knowledge about COPD and its risk factors and management among both patients, the public and primary healthcare professionals. We provide important content for the formulation of public policies for the implementation of specific activity programmes for people with COPD in community spaces using local resources and intersectoral partnerships.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>S M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1798-3854</Identifier><AffiliationInfo><Affiliation>Health Services Management Centre, School of Social Policy and Society, University of Birmingham, Birmingham, UK. r.l.adams@bham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>E M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stelmach</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Respiratory Division, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adab</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9087-3945</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General Practice, Peking University First Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>K K</ForeName><Initials>KK</Initials><Identifier Source="ORCID">0000-0002-1516-1857</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>B G</ForeName><Initials>BG</Initials><AffiliationInfo><Affiliation>Lung Function &amp; Sleep, Queen Elizabeth Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correia-de-Sousa</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6459-7908</Identifier><AffiliationInfo><Affiliation>International Primary Care Respiratory Group, Larbert, Scotland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, PT Government Associate Laboratory, ICVS/3B's, University of Minho, Braga/Guimar&#xe3;es, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickens</LastName><ForeName>A P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational and Pragmatic Research Institute, Midview City, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enocson</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4415-0989</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farley</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4370-0264</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gale</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Health Services Management Centre, School of Social Policy and Society, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jolly</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6224-2115</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>R E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-0747-6883</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jowett</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8936-3745</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maglakelidze</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maghlakelidze</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sitch</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health and Care Research (NIHR), Birmingham Biomedical Research Centre, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stavrikj</LastName><ForeName>K</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-8319-4554</Identifier><AffiliationInfo><Affiliation>Center for Family Medicine, Faculty of Medicine, Ss.Cyril and Methodius University in Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>A M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-5947-3254</Identifier><AffiliationInfo><Affiliation>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>International Primary Care Respiratory Group, Larbert, Scotland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nascimento</LastName><ForeName>V B</ForeName><Initials>VB</Initials><AffiliationInfo><Affiliation>Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Prim Care Respir Med</MedlineTA><NlmUniqueID>101631999</NlmUniqueID><ISSNLinking>2055-1010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>P.Ad. declares grant funding paid to her institution from NIHR, MRC and Colt Foundation, funding to Institution and to cover expenses as Chair of NIHR Public Health Research Funding Committee, Deputy Director of NIHR School for Public Health Research, funding to cover expense as Member of Wellcome Trust Early Career Advisory Group in Population and Public Health, Output Assessor for Panel A, subpanel 2 in 2021 Research Excellence Framework, and unfunded contributions as Chair for several NIHR funded TSCs, Member of the MRC funded Natural Experiments Evaluations Project Oversight Group, Member of Obesity Health Alliance Independent Obesity Strategy Working Group, Member of NIHR palliative and End of Life Care Research Partnerships call Panel, NIHR/UKRI Long COVID funding call Panel, NIHR COVID-19 Recovery and Learning Funding Committee; J.C-De-S. declares grant funding to his institution from AstraZeneca and GSK, advisory board and consulting fees paid to himself from Boheringer Ingelheim, GSK, AstraZeneca, Bial, Medinfar, Payment for lectures from GSK, AstraZeneca and Sanofi Pasteur, support for attending meetings from Mundipharma and Mylan, leadership role for International Primary Care Respiratory Group (IPCRG); A Farley declares grant funding paid to her institution from NIHR GHR for the present manuscript, grant funding from NIHR HTA, NIHR EME, MRC and Ethicon (Johnson and Johnson) for other work, membership on DMEC for NIHR funded e-cigarette trial (no honorarium), leadership role for International Primary Care Respiratory Group (IPCRG) and as expert funding panel member for Cancer Research UK personal funding for; K.J. declares grant funding paid to her institution from NIHR and MRC, participant in Data Safety Monitoring Board or advisory board for NIHR funded studies (no honorarium), Sub-committee chair of NIHR Programme Grants for Applied Health Research (payments to institution); R.J. declares grant funding to her institution from NIHR, membership of Boehringer Ingelheim Primary Care Advisory Board, unfunded leadership role for International Primary Care Respiratory Group (IPCRG) &#x2013; research sub-committee, membership of NIHR Global Health Group panel and RfPB COPD Highlight panel; S.J. declares grant funding to her institution from NIHR GHR for present manuscript and unfunded membership of the HTA Funding Committee Policy Group (formerly CSG) and the HTA Clinical Evaluation and Trials Committee; S.M.M. declares leadership or fiduciary do GEPRAPS (Respiratory Group of Study and Research in Primary Care) of Center for Public Health Studies (CESCO) at the University Center of the ABC Medical School, S&#xe3;o Paulo, Brazil, IPCRG (Internacional Primary Care Respiratory Group); A Sitch declares grant funding to her institution from NIHR GHR for present manuscript, NIHR Birmingham BRC and AstraZeneca; A Turner declares grant funding to her institution from NIHR GHR for present manuscript, grant funding from AstraZeneca and Chiesi for other work, payment of honoraria from GSK and Boehringer, support for attending meetings and/or travel from AstraZeneca and Chiesi; S.W. declares grants from the University of Birmingham paid to her institution, her institution has received conference sponsorship and independent educational grants from Pfizer Global Medical Grants, AstraZeneca, GSK, Boehringer Ingelheim, Vitalograph, Caire Diagnostics and Thorasys; R.A., K.K.C., C.Chi., B.C., A.D., A.E., N.G., T.M., M.M., K.S., S.R. declare grant funding to their institution from NIHR GHR for current manuscript; V.B.N., E.R. have no financial or non-financial conflicts to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39455598</ArticleId><ArticleId IdType="pmc">PMC11511987</ArticleId><ArticleId IdType="doi">10.1038/s41533-024-00386-7</ArticleId><ArticleId IdType="pii">10.1038/s41533-024-00386-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2016 Brazil Collaborators. Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet392, 760&#x2013;775 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6123514</ArticleId><ArticleId IdType="pubmed">30037735</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabahi, M. Epidemiology of COPD: facing challenges. Pulm&#xe3;o RJ22, 4&#x2013;8 (2013).</Citation></Reference><Reference><Citation>Christenson, S. A., Smith, B. M., Bafadhel, M. &amp; Putcha, N. Chronic obstructive pulmonary disease. Lancet399, 2227&#x2013;2242 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35533707</ArticleId></ArticleIdList></Reference><Reference><Citation>Miravitlles, M. &amp; Ribera, A. Understanding the impact of symptoms on the burden of COPD. Respir. Res.18, 67 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5399825</ArticleId><ArticleId IdType="pubmed">28431503</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell, D. E., Milne, K. M., James, M. D., de Torres, J. P. &amp; Neder, J. A. Dyspnea in COPD: new mechanistic insights and management implications. Adv. Ther.37, 41&#x2013;60 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6979461</ArticleId><ArticleId IdType="pubmed">31673990</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado, A. et al. Burtin C. Impact of acute exacerbations of COPD on patients&#x2019; health status beyond pulmonary function: a scoping review. Pulmonology14, S2531&#x2013;0437 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35715333</ArticleId></ArticleIdList></Reference><Reference><Citation>Putcha, N., Drummond, M. B., Wise, R. A. &amp; Hansel, N. N. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin. Respir. Crit. Care Med.36, 575&#x2013;591 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5004772</ArticleId><ArticleId IdType="pubmed">26238643</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforest, L. et al. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: a population-based cohort study. Respir. Med.117, 33&#x2013;39 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27492511</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey, C. &amp; Criner, G. J. Impact of comorbidities on the treatment of chronic obstructive pulmonary disease. Am. J. Med.131, 23&#x2013;29 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29777661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiani, F. Z. &amp; Ahmadi, A. Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran. Sci. Rep.11, 1548 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810834</ArticleId><ArticleId IdType="pubmed">33452286</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos, N. C. D. et al. Prevalence and impact of comorbidities in individuals with chronic obstructive pulmonary disease: a systematic review. Tuberc. Respir. Dis.85, 205&#x2013;220 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9263346</ArticleId><ArticleId IdType="pubmed">35618259</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohannes, A. M., Kaplan, A. &amp; Hanania, N. A. COPD in primary care: key considerations for optimized management: anxiety and depression in chronic obstructive pulmonary disease: recognition and management. J. Fam. Pract.67, S11&#x2013;S18 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29443332</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima, C. A. et al. Quality of life, anxiety and depression in patients with chronic obstructive pulmonary disease. Rev. Bras Enferm.73, e20190423 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32667477</ArticleId></ArticleIdList></Reference><Reference><Citation>YIN, H. L. et al. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: a meta-analysis. Medicine96, e6836 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428602</ArticleId><ArticleId IdType="pubmed">28489768</ArticleId></ArticleIdList></Reference><Reference><Citation>Pumar, M. I. et al. Anxiety and depression-Important psychological comorbidities of COPD. J. Thorac. Dis.6, 1615&#x2013;1631 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4255157</ArticleId><ArticleId IdType="pubmed">25478202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J., Willis, K., Barson, E. &amp; Smallwood, N. The complexity of mental health care for people with COPD: a qualitative study of clinicians&#x2019; perspectives. NPJ Prim. Care Respir. Med.31, 40 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298614</ArticleId><ArticleId IdType="pubmed">34294727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Gestoso, S. et al. Impact of anxiety and depression on the prognosis of copd exacerbations. BMC Pulm. Med.22, 169 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9052487</ArticleId><ArticleId IdType="pubmed">35488330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandes, N. A. et al. Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J. Bras Pneumol.35, 949&#x2013;956 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19918626</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitta, F. et al. Comparison of daily physical activity between People with COPD from Central Europe and South America. Respir. Med.103, 421&#x2013;426 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19006659</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, K. C. Physical activity in chronic obstructive pulmonary disease: clinical impact and risk factors. Korean J. Intern. Med.33, 75&#x2013;77 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5768551</ArticleId><ArticleId IdType="pubmed">29334725</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyssen, S. M. et al. Levels of physical activity and predictors of mortality in COPD. J. Bras Pneumol.39, 659&#x2013;666 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075906</ArticleId><ArticleId IdType="pubmed">24473759</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, G. M. et al. Smoking cessation for improving mental health. Cochrane Database Syst. Rev.3, CD013522 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121093</ArticleId><ArticleId IdType="pubmed">33687070</ArticleId></ArticleIdList></Reference><Reference><Citation>Action on Smoking and Health [ASH], Royal College of Psychiatrists, Public Mental Health Implementation Centre. Public mental health and smoking. A framework for action. https://ash.org.uk/uploads/Public-mental-health-and-smoking.pdf?v=1659737441 (2022).</Citation></Reference><Reference><Citation>Gimeno-Santos, E. et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax69, 731&#x2013;739 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112490</ArticleId><ArticleId IdType="pubmed">24558112</ArticleId></ArticleIdList></Reference><Reference><Citation>Due&#xf1;as-Esp&#xed;n, I. et al. Depression symptoms reduce physical activity in People with COPD: a prospective multicenter study. Int. J. Chron. Obstruct. Pulmon. Dis.11, 1287&#x2013;1295 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910613</ArticleId><ArticleId IdType="pubmed">27354787</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang, X., Huang, L., Fang, Y., Cai, S. &amp; Zhang, M. Physical activity and chronic obstructive pulmonary disease: a scoping review. BMC Pulm. Med.22, 301 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9354440</ArticleId><ArticleId IdType="pubmed">35932050</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado, A., Oliveira, A., Valente, C., Burtin, C. &amp; Marques, A. Effects of a community-based pulmonary rehabilitation programme during acute exacerbations of chronic obstructive pulmonary disease - A quasi-experimental pilot study. Pulmonology26, 27&#x2013;38 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31164288</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit, M. A., Pitta, F., McAuley, E., ZuWallack, R. L. &amp; Nici, L. Pulmonary rehabilitation and physical activity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.192, 924&#x2013;933 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26161676</ArticleId></ArticleIdList></Reference><Reference><Citation>Strawbridge, W. J., Deleger, S., Roberts, R. E. &amp; Kaplan, G. A. Physical activity reduces the risk of subsequent depression for older adults. Am. J. Epidemiol.156, 328&#x2013;334 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaczynski, A. T., Manskem, S. R., Mannellm, R. C. &amp; Grewal, K. Smoking and physical activity: a systematic review. Am. J. Health Behav.32, 93&#x2013;110 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18021037</ArticleId></ArticleIdList></Reference><Reference><Citation>Meshe, O. F., Claydon, L. S., Bungay, H. &amp; Andrew, S. The relationship between physical activity and health status in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation. Disabil. Rehabil.39, 746&#x2013;756 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27049603</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques, A. et al. Improving access to community-based pulmonary rehabilitation: 3R protocol for real-world settings with cost-benefit analysis. BMC Public Health19, 676 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6544941</ArticleId><ArticleId IdType="pubmed">31151409</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa, M., Andrade, R., de Melo, C. A. &amp; Torres, R. Community-based pulmonary rehabilitation programs in individuals with COPD. Respir. Care67, 579&#x2013;593 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35473839</ArticleId></ArticleIdList></Reference><Reference><Citation>Neves, L. F., Reis, M. H. &amp; Gon&#xe7;alves, T. R. Home or community-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Cad. Saude Publica32, e00085915 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27333130</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Avila, O. P. et al. Use of health services and family health strategy households population coverage in Brazil. Cienc Saude Colet26, 3955&#x2013;3964 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34586251</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins, S. M. et al. Accuracy and economic evaluation of screening tests for undiagnosed COPD among hypertensive individuals in Brazil. NPJ Prim Care Respir. Med.32, 55 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9747958</ArticleId><ArticleId IdType="pubmed">36513683</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, R. S. Purposive Sampling. in Encyclopedia of Quality of Life and Well-Being Research (eds Michalos, A. C.) (Springer, 2014).</Citation></Reference><Reference><Citation>Kovelis, D. et al. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J. Bras Pneumol.34, 1008&#x2013;1018 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">19180335</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, G. P. F., Morano, M. T. A. P., Viana, C. M. S., Magalhaes, C. B. A. &amp; Pereira, E. D. B. Portuguese-language version of the COPD assessment test: validation for use in Brazil. J. Bras Pneumol.39, 402&#x2013;408 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075870</ArticleId><ArticleId IdType="pubmed">24068260</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos, I. S. et al. Sensitivity and specificity of the Patient Health Questionnaire-9 (PHQ-9) among adults from the general population. Cad Saude Publica29, 1533&#x2013;1543 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24005919</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergerot, C. D., Laros, J. A. &amp; Araujo, T. C. C. F. Avalia&#xe7;&#xe3;o de ansiedade e depress&#xe3;o em pacientes oncol&#xf3;gicos: compara&#xe7;&#xe3;o psicom&#xe9;trica. Psico-USF19, 187&#x2013;197 (2014).</Citation></Reference><Reference><Citation>Spitzer, R. L., Kroenke, K., Williams, J. B. &amp; L&#xf6;we, B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med.166, 1092&#x2013;1097 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan, P., Shedden-Mora, M. C. &amp; L&#xf6;we, B. Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory. PLoS ONE12, e0182162 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5542568</ArticleId><ArticleId IdType="pubmed">28771530</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe3;o-Jo&#xe3;o, T. M. et al. Cultural adaptation of the Brazilian version of the Godin-Shephard Leisure-Time Physical Activity questionnaire. Rev. Saude Publica47, 479&#x2013;487 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24346560</ArticleId></ArticleIdList></Reference><Reference><Citation>Amireault, S., Godin, G., Lacombe, J. &amp; Sabiston, C. M. The use of the Godin-Shephard Leisure-Time Physical Activity Questionnaire in oncology research: a systematic review. BMC Med. Res. Methodol.15, 60 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4542103</ArticleId><ArticleId IdType="pubmed">26264621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouveia, V. V., Lima, T. J. S., Gouveia, R. S. V., Freires, L. A. &amp; Barbosa, L. H. G. M. General Health Questionnaire (GHQ-12): the effect of negative items in its factorial structure. Cad Saude Publica28, 375&#x2013;384 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22331163</ArticleId></ArticleIdList></Reference><Reference><Citation>Anjara, S. G., Bonetto, C., Van Bortel, T. &amp; Brayne, C. Using the GHQ-12 to screen for mental health problems among primary care patients: psychometrics and practical considerations. Int. J. Ment. Health Syst.14, 1&#x2013;13 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418321</ArticleId><ArticleId IdType="pubmed">32793301</ArticleId></ArticleIdList></Reference><Reference><Citation>Moises, C. Jr Online data collection as adaptation in conducting quantitative and qualitative research during the COVID-19 pandemic. Eur. J. Educ. Stud.7, 79&#x2013;89 (2020).</Citation></Reference><Reference><Citation>Baillie, L. Promoting and evaluating scientific rigour in qualitative research. Nurs. Stand.29, 36&#x2013;42 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26174283</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, J. L., Adkins, D. &amp; Chauvin, S. A review of the quality indicators of Rigor in Qualitative Research. Am. J. Pharm. Educ.84, 7120 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7055404</ArticleId><ArticleId IdType="pubmed">32292186</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, J. &amp; Firth, J. Qualitative data analysis: the framework approach. Nurs. Res.18, 52&#x2013;62 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21319484</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale, N. K., Heath, G., Cameron, E., Rashid, S. &amp; Redwood, S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med. Res. Methodol13, 117 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848812</ArticleId><ArticleId IdType="pubmed">24047204</ArticleId></ArticleIdList></Reference><Reference><Citation>de Queiroz, M. C. et al. Knowledge about COPD among users of primary health care services. Int. J. Chron. Obstruct Pulmon. Dis.10, 1&#x2013;6 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4279667</ArticleId><ArticleId IdType="pubmed">25565794</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeloye, D. et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir. Med.10, 447&#x2013;458 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9050565</ArticleId><ArticleId IdType="pubmed">35279265</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, H. et al. Disease knowledge and self-management behavior of People with COPD in China. Medicine98, e14460 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6408037</ArticleId><ArticleId IdType="pubmed">30813148</ArticleId></ArticleIdList></Reference><Reference><Citation>Enocson, A. et al. Case-finding for COPD in primary care: a qualitative study of patients&#x2019; perspectives. Int. J. Chron. Obstruct Pulmon. Dis.13, 1623&#x2013;1632 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963478</ArticleId><ArticleId IdType="pubmed">29844668</ArticleId></ArticleIdList></Reference><Reference><Citation>Vachon, B. et al. Challenges and Strategies for Improving COPD Primary Care Services in Quebec: Results of the Experience of the COMPAS+ Quality Improvement Collaborative. Int. J. Chron. Obstruct Pulmon. Dis.17, 259&#x2013;272 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8819163</ArticleId><ArticleId IdType="pubmed">35140460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharbanda, S. &amp; Anand, R. Health-related quality of life in patients with chronic obstructive pulmonary disease: a hospital-based study. Indian J. Med. Res.153, 459&#x2013;464 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354058</ArticleId><ArticleId IdType="pubmed">34380792</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Leupoldt, A. Treating anxious expectations can improve dyspnoea in patients with COPD. Eur. Respir. J. 50, 1701352 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28899940</ArticleId></ArticleIdList></Reference><Reference><Citation>Spathis, A. et al. Cutting through complexity: the Breathing, Thinking, Functioning clinical model is an educational tool that facilitates chronic breathlessness management. NPJ Prim. Care Respir. Med.31, 25 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110567</ArticleId><ArticleId IdType="pubmed">33972569</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiemensma, J., Gaab, E., Voorhaar, M., Asijee, G. &amp; Kaptein, A. A. Illness perceptions and coping determine quality of life in People with COPD. Int. J. Chron. Obstruct. Pulmon. Dis.11, 2001&#x2013;2007 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003510</ArticleId><ArticleId IdType="pubmed">27601893</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarab, A., Alefishat, E., Mukattash, T., Alzoubi, K. &amp; Pinto, S. Patients&#x2019; perspective of the impact of COPD on quality of life: a focus group study for patients with COPD. Int. J. Clin. Pharm.40, 573&#x2013;579 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29542033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarghami, M., Taghizadeh, F., Sharifpour, A. &amp; Alipour, A. Efficacy of smoking cessation on stress, anxiety, and depression in smokers with chronic obstructive pulmonary disease: a randomized controlled clinical trial. Addict. Health10, 137 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6511395</ArticleId><ArticleId IdType="pubmed">31105911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosteli, M.-C. et al. Barriers and enablers of physical activity engagement for patients with COPD in primary care. Int. J. Chron. Obstruct. Pulmon. Dis.12, 1019&#x2013;1031 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5378459</ArticleId><ArticleId IdType="pubmed">28405162</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, H., Williams, V., Curtis, F., Bridle, C. &amp; Jones, A. W. Facilitators and barriers to physical activity following pulmonary rehabilitation in COPD: a systematic review of qualitative studies. NPJ Prim. Care Respir. Med.28, 19 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986863</ArticleId><ArticleId IdType="pubmed">29867117</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogra, S. et al. Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease. BMC Pulm. Med.18, 98 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5992845</ArticleId><ArticleId IdType="pubmed">29879930</ArticleId></ArticleIdList></Reference><Reference><Citation>Instituto Brasileiro de Geografia e Estat&#xed;stica (IBGE). Censo 2022-Panoramahttps://censo2022.ibge.gov.br/panorama/ (2022).</Citation></Reference><Reference><Citation>Instituto Brasileiro de Geografia e Estat&#xed;stica (IBGE). Sinopse do Censo Demogr&#xe1;fico 2010https://www.ibge.gov.br/censo2010/apps/sinopse/index.php?dados=P9&amp;uf=00 (2011).</Citation></Reference><Reference><Citation>Hume, E. et al. Impact of COVID-19 shielding on physical activity and quality of life in patients with COPD. Breathe16, 200231 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7792782</ArticleId><ArticleId IdType="pubmed">33447283</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohannes, A. M. People with COPD in a COVID-19 society: depression and anxiety. Expert Rev. Respir. Med.15, 5&#x2013;7 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32578464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>